K. Gebhardt

Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regeneration.

T. Gruenberger, E. Fleischmann, P. Starlinger, 2013, Journal of hepatology.

Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs

S. Kozek-Langenecker, G. Scharbert, E. Deusch, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The Perioperative Angiogenic Balance Is Sensitive to Systemic Thrombospondin-1 Levels

T. Gruenberger, S. Roka, B. Gruenberger, 2008, Clinical Cancer Research.

Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells

M. Gruber, Anika C. Bundscherer, C. Wiese, 2015, BMC Anesthesiology.

NeoadjuvantTreatment of Colorectal Cancer with Bevacizumab : The PerioperativeAngiogenic Balance Is Sensitive to SystemicThrombospondin-1 Levels

S. Roka, B. Gruenberger, C. Brostjan, 2008 .

Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro.

T. Metterlein, M. Gruber, C. Plank, 2015, Pharmacological research.

Independent effects of arbuscular mycorrhiza and earthworms on plant diversity and newcomer plant establishment

M. Rillig, Susanne Wurst, K. Gebhardt, 2011 .

Systemic effects of anti-VEGF therapy – Mini-review

P. Starlinger, C. Brostjan, K. Gebhardt, 2010, European Surgery.

Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro.

T. Metterlein, M. Gruber, C. Plank, 2015, Pharmacological research.